Prevention of radiocontrast nephropathy - What are the facts;Was ist gesichert in der pravention der kontrastmittelnephropathie?

Medizinische Klinik

Volumn 92, Issue 6, 1997, Pages 329-334

  Friedrichsohn, Christian Björn ^a   Riegel, Werner ^b   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Inn Med IV Nieren H ^*

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

CONTRAST RADIOGRAPHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; REVIEW; RISK FACTOR;

EID: 0030745282     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03044773     Document Type: Review

References (73)

1. Anto, H. R., S. Y. Chou, J. G, Porush, W. B. Shapiro: Infusion intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency. Arch. intern. Med. 141 (1981), 1652-1656.
2. Arakawa, K., H. Suzuki, M. Naitoh, A. Matsumoto, A. Ichihara, K. Oka, T. Saruta: Adenosine A1-receptor antagonist KW3902 completely prevents non-ionic radiocontrast-induced nephropathy in conscious dogs with renal insufficiency. J. Amer. Soc. Nephrol. 5 (1994), 916.
3. Arend, L. J., G, L. Bakris, J. C. J. Burnett, C. Megerian, W. S. Spielman: Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J. Lab. clin Med. 110 (1987), 406-411.
4. Bakris, G. L., J, C. J. Burnett: A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney int. 27 (1985), 465-468.
5. Bakris, G. L., A. O. Gaber, J. D. Jones: Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium. Radiology 175 (1990), 57-60.
6. Barrett, B J.: Contrast nephrotoxicity. J. Amer. Soc. Nephrol. 5 (1994), 125-137.
7. Barrett, B. J., E. J. Carlisle: Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993), 171-178.
8. Barrett, B. J., P. S. Parfrey: Prevention of nephrotoxicity induced by radiocontrast agents. New Engl. J. Med. 331 (1994), 1449-1450.
9. Barrett, B. J., P. S. Parfrey, H. M. Vavasour, J. McDonald, G. Kent, D. Hefferton, F. O'Dea, E. Stone, R. Reddy, P. J. McManamon: Contrast nephropathy in patients with impaired renal function, high versus low osmolar media. Kidney int. 41 (1992), 1274-1279.
10. Berdon, W. E., R. H. Schwartz, J. Becker, D. H. Baker: Tamm-Horsfall proteinurta. Its relationship to prolonged nephrogram in infants and children and to renal failure following intravenous urography in adults with multiple myeloma. Radiology 92 (1969), 714-722.
11. Berkseth, R. O., C. M. Kjellstrand: Radiologic contrastinduced nephropathy. Med. Clin. N. Amer. 68 (1984), 351-370.
12. Berns, A. S.: Nephrotoxicity of contrast media. Kidney int. 36 (1989), 730-740.
13. Bettmann, M. A.: The evaluation of contrast-related renal failure. Amer. J. Roentgenol. 157 (1991), 66-68.
14. Byrd, L., R. L, Sherman: Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine (Baltimore) 58 (1979), 270-279.
15. Cantley, L. G., K. Spokes, B. Clark, E. G. McMahon, J. Carter, F. H. Epstein: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney int. 44 (1993), 1217-1223.
16. Cigarroa, R. G., R, A. Lange, R. H. Williams, L.D. Hillis: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Amer. J. Med. 86 (1989), 649-652.
17. Cochran, S. T., W. S. Wong, D. J. Roe: Predicting angiography-induced acute renal function impairment: clinical risk model. Amer. J. Roentgenol. 141 (1983), 1027-1033.
18. Cohen, D. J., W. H. Sherman, E. F. Osserman, G. B. Appel: Acute renal failure in patients with multiple myeloma. Amer. J. Med. 76 (1984), 247-256.
19. Conger, J. D.: Interventions in clinical acute renal failure: What are the data? Amer. J. Kidney Dis. 26 (1995), 565-576.
20. Conlon, P. J., S. J. Schwab: Time to abandon nonionic contrast. J. Amer Soc. Nephrol. 5 (1994), 123-124.
21. D'Elia, J. A., R. E. Gleason, M. Alday, C. Malarick, K. Godley, J. Warram, A. Kaldany, L A. Weinrauch: Nephrotoxicity from angiographic contrast material. A prospective study. Amer. J. Med. 72 (1982), 719-725.
22. Davidson, C. J., M. Hlatky, K. G. Morris, K. Pieper, T. N. Skelton, S J. Schwab, T. M. Bashore: Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann. intern. Med 110 (1989), 119-124
23. Deray, G., F. Martinez, P. Cacoub, B. Baumelou, A. Baumelou, C. Jacobs: A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Amer. J. Nephrol. 10 (1990), 316-322.
24. Eisenberg, R. L., W. O Bank, M. W. Hedgock: Renal failure after major angiography can be avoided with hydration Amer. J. Roentgenol. 136 (1981), 859-861.
25. Fang, L. S., R. A. Sirota, T. H. Ebert, N. S. Lichtenstein: Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch. intern. Med. 140 (1980), 531-533.
26. Gelman, M. L., J. W. Rowe, C. H. Coggins, C. Athanasoulis: Effects of an angiographic contrast agent on renal function. Cardiovasc. Med. 4 (1979), 313-315.
27. Gomes, A. S., J. F. Lois, J. D. Baker, C. T. McGlade, D. H. Bunnell, S. Hartzman: Acute renal dysfunction in high-risk patients after angiography: comparison of ionic and nonionic contrast media. Radiology 170 (1989), 65-68.
28. Gurkowski, L., M. MacDougall, T. Wiegmann: Prevention of contrast induced renal dysfunction by misoprostil: results of a prospective, randomized, double-blind study. J. Amer. Soc. Nephrol. 5 (1994), 923.
29. Hall, K. A., R. W. Wong, G. C. Hunter, B. M. Camazine, W. A. Rappaport, S. H. Smyth, D. A. Bull, K. E. McIntyre, V. M. Bernhard, R. L. Misiorowski: Contrastinduced nephrotoxicity: the effects of vasodilator therapy. J. surg. Res. 53 (1992), 317-320.
30. Hans, B., S. S. Hans, V. K. Mittal, T. A. Khan, N. Patel, M. S. Dahn: Renal functional response to doparnine during and after arteriography in patients with chronic renal insufficiency. Radiology 176 (1990), 651-654.
31. Harris, K. G., T. P. Smith, A. H. Cragg, J. H. Lemke: Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents Radiology 179 (1991), 849-852.
32. Heneghan, M.: Contrast-induced acute renal failure. Amer. J. Roentgenol. 131 (1978), 1113-1115.
33. Heyman, S. N., M. Brezis, F. H. Epstein, K. Spokes, P. Silva, S. Rosen: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney int. 40 (1991), 632-642.
34. Holland, M. D., J H. Galla, P. W. Sanders, R. G. Luke: Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat. Kidney int. 27 (1985), 46-50.
35. Hou, S. H., D. A. Bushinsky, J. B. Wish, J. J. Cohen, J. T. Harrington: Hospital-acquired renal insufficiency: a prospective study. Amer. J. Med. 74 (1983), 243-248.
36. Huhn, H. W., H. J. Tönnis, E-Schmidt: Elimination von Röntgenkontrastmitteln durch Hämodialyse. Nieren- u. Hochdruckkrh. 22 (1993), 45-52.
37. Jevnikar, A. M., K. J. Finnie, B. Dennis, D. T. Plummer, A. Avila, A. L. Linton Nephrotoxicity of high- and low-osmolality contrast media. Nephron 48 (1988), 300-305.
38. Larson, T. S., K. Hudson, J. I. Mertz, J. C. Romero, F. G. Knox: Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system. J. Lab chn. Med. 101 (1983), 385-391.
39. Lautin, E. M., N. J. Freeman, A. H. Schoenfeld, C. W. Bakal, N Haramati, A. C. Friedman, J. L. Lautin, S. Braha, E. G. Kadish, S. Sprayregen et al: Radiocontrast-associated renal dysfunction: incidence and risk factors. Amer. J. Roentgenol. 157 (1991), 49-58.
40. Lederbogen, S., D. Reinwein: Epidemiologische Daten zur thyreotoxischen Krise, eine retrospektive Untersuchung Akt. Endokr. Stoffw. 13 (1992), 82-84.
41. Manske, C. L., J. M. Sprafka, J. T. Strony, Y. Wang: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Amer. J. Med. 89 (1990), 615-620.
42. Mason, R. A., L. A. Arbeit, F. Giron: Renal dysfunction after arteriography. J. Amer. med. Ass. 253 (1985), 1001-1004
43. McCarthy, C. S., J. A. Becker: Multiple myeloma and contrast media. Radiology 183 (1992), 519-521.
44. Moon, S. S., S.-T. Baeck, J. Kurkus, P. Nilsson-Ehle: Hemodialysis for elimination of the nonionic contrast medium tohexol after angiography in patients with impaired renal function. Nephron 70 (1995), 430-437.
45. Moore, R. D., E. P. Steinberg, N. R. Powe, J. A. Brinker, E. K. Fishman, S. Graziano, R. Gopalan: Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 182 (1992), 649-655.
46. Moreau, J. F., D. Droz, J. Sabto, P. Jungers, D. Kleinknecht, N. Hinglais, J. R. Michel: Osmotic nephrosis induced by water-soluble triiodinated contrast media in man. A retrospective study of 47 cases. Radiology 115 (1975), 329-336.
47. Mudge, G. H : Nephrotoxicity of urographic radiocontrast drugs. Kidney int 18 (1980), 540-552.
48. Neumayer, H. H., W. Junge, A. Kufner, A. Wenning: Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrol. Dial. Transplant 4 (1989), 1030-1036.
49. Old, C. W., L. M Lehrner Prevention of radiocontrast induced acute renal failure with mannitol Lancet 1 (1980), 885.
50. Parfrey, P. S., S. M. Griffiths, B. J. Barrett, M. D. Paul, M. Genge, J. Withers, N. Fand, P. J. McManamon: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. New Engl J. Med. 320 (1989), 143-149.
51. Potter, G. A.: Contrast-associated nephropathy. Amer. J. Cardiol. 64 (1989), 22E-26E.
52. Postlethwaite, A. E., W. N. Kelley. Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations Ann. intern. Med. 74 (1971), 845-852.
53. Postlethwaite, A. E., W. N. Kelley: Radiocontrast agents and aspirin J. Amer. med. Ass. 219 (1972), 1479.
54. Powe, N. R.: Low-versus high-osmolality contrast media for intravenous use: a health care luxury or necessity? Radiology 183 (1992), 21-22.
55. Read, R. C., M. Meyer: The role of red cell agglutination in arteriographic complications. Surg. Forum 10 (1959), 472-475.
56. Rich, M. W., C. A. Crecelius: Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch. intern. Med. 150 (1990), 1237-1242.
57. Rudnick, M. R., J. S. Berns, R. M Cohen, S. Goldfarb: Nephrotoxic risks of renal angiography: contrast mediaassociated nephrotoxicity and atheroembolism - a critical review. Amer. J. Kidney Dis. 24 (1994), 713-727.
58. Russo, D., A. Testa, L. Della Volpe, G Sansone: Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron 55 (1990), 254-257.
59. Schaller, U., D. Holzel, C. Kirsch, D. Engelhardt: The spontaneous course of compensated autonomous thyroid gland adenomas. Klin. Wschr. 69 (1991), 786-792.
60. Schwab, S. J., M. A. Hlatky, K. S. Pieper, C. J. Davidson, K G. Morris, T. N, Skelton, T, M. Bashore: Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent New Engl. J. Med 320 (1989), 149-153.
61. Schwartz, R. H., W E. Berdon, J. Wagner, J Becker, D. H. Baker: Tamm-Horsfall urinary mucoprotein precipitation by urographic contrast agents: in vitro studies. Amer. J. Roentgenol. Radium Ther. Nucl. Med. 108 (1970), 698-701.
62. Shusterman, N., B. L. Strom, T. G. Murray, G. Morrison, S. L. West, G. Maishn: Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study Amer. J. Med 83 (1987), 65-71.
63. Solomon, R., C Werner, D. Mann, J. D'Eha, P. Silva:Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents New Engl J. Med. 331 (1994), 1416-1420.
64. Taliercio, C. P., R. E Vlietstra, L. D. Fisher, J. C. Burnett: Risks for renal dysfunction with cardiac angiography. Ann intern Med. 104 (1986), 501-504
65. Teruel, J L., R. Marcen, J M. Onaindia, A. Serrano, C. Quereda, J. Ortuno: Renal function impairment caused by intravenous urography. A prospective study Arch. intern. Med 141 (1981), 1271-1274.
66. Tschakeri, H., R. Matern-Pinzek, J. Schaffelt; Anstieg von Nierenenzymen im Harn nach Kontrastmittelgabe: Vergleich der Nephrotoxizitat ionischer und nichtionischer Praparate. Akt. Radiol. 5 (1995), 152-156.
67. VanZee, B E., W. E Hoy, T. E Talley, J. R. Jaenike: Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients Ann. intern Med. 89 (1978), 51-54.
68. Weinrauch, L. A., R W Healy, O. S J Leland, H. H. Goldstein, S D Kassissieh, J A. Libertino, F. J. Takacs, J. A D'Eha: Coronary angiography and acute renal failure in diabetic azotemic nephropathy Ann. intern Med. 86 (1977), 56-59
69. Weinstein, J M., S Heyman, M. Brezis Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62 (1992), 413-415.
70. Weisberg, L S., P. B Kurnik, B. R Kurnik: Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction Kidney int 41 (1992), 1408-1415.
71. Weisberg, L. S., P B Kurnik, B R Kurnik Risk of radiocontrast nephropathy in patients with and without diabetes mellitus Kidney int. 45 (1994), 259-265
72. Weisberger, L S., P S Kurnik, B S Kurnik: Dopamine and renal blood flow in radiocontrast induced nephropathy in humans. Renal Failure 15 (1993), 61-67.
73. Yoshioka, T., A. Fogo, J. K. Beckman: Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney int. 41 (1992), 1008-1015.